Financial statements Emergopharm Spółka Z Ograniczoną Odpowiedzialnością

Balance sheet of Emergopharm Spółka Z Ograniczoną Odpowiedzialnością

Company age:
Age:
11 y. 8 m. 9 d.
Profit and loss statement Balance Profitability

Balance sheet data of EMERGOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Year
2021
2022
2023
Total assets 14 872 298,01 13 599 701,41 16 166 037,96
A. Fixed assets 66 177,08 273 766,29 291 932,30
B. Current assets 14 806 120,93 13 325 935,12 15 874 105,66
C. Share capital contributions (basic funds) - - -
D. Own shares (stocks) - - -
Total liabilities 14 872 298,01 13 599 701,41 16 166 037,96
A. Equity 9 075 233,41 9 074 632,83 7 287 920,62
B. Liabilities and provisions for liabilities 5 797 064,60 4 525 068,58 8 878 117,34
I. Long-term liabilities - - -
II. Short-term liabilities 5 797 064,60 4 525 068,58 8 878 117,34
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.